Scribd
Upload
819 views1 page

Combivent

This document summarizes information about the drug Combivent, which contains salbutamol and iprafropium. It is a bronchodilator used to treat bronchospasm via nebulizer every 8 hours. Potential side effects include fatigue, abdominal pain, and hypertension. It is indicated for relief and prevention of bronchospasm in patients with obstructive airway disease. Nurses should monitor the patient's respiratory status before and after treatment.

Uploaded by

leroux2890
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
819 views1 page

Combivent

This document summarizes information about the drug Combivent, which contains salbutamol and iprafropium. It is a bronchodilator used to treat bronchospasm via nebulizer every 8 hours. Potential side effects include fatigue, abdominal pain, and hypertension. It is indicated for relief and prevention of bronchospasm in patients with obstructive airway disease. Nurses should monitor the patient's respiratory status before and after treatment.

Uploaded by

leroux2890
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 1

Ateneo de Zamboanga University College of Nursing

Drug Generic Name: Salbutamol Iprafropium Brand Name: (Combivent) Dosage: Route: Nebule Frequency: q8

Mechanism of Action Classification: Bronchodilator Beta2 Adrenergic agonist and anticholinergic Mechanism of Action: Beta2 adrenergic receptor cause bronchodilation and vasodilation Anticholinergic, blocks reflexes by antagonizing action of acetylcholine

Side Effects/ Adverse Effects Fatigue, abdominal pain, hypertension, dyspepsia, tachycardia, sinusitis, dysuria, urinary retention, weakness, edema, vomiting diarrheal constipation

Indication/ Contraindication Indication: Relief and prevention of bronchospasm in patients with airway obstructive disease Bronchodilator

Nursing Responsibilities

Monitor respiratory status, auscultate lungs before and after nebulization Report treatment failure or exacerbation of Contraindication: respiratory Patient with cardiac symptoms to tachyarrythmias, physician hypertropic Do not allow solution obstructive cardiomyopathy and or mist to enter the patient with history of eyes hypersensitivity

You might also like